2,100,000 Shares in SPDR S&P Biotech ETF $XBI Acquired by Avoro Capital Advisors LLC

Avoro Capital Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 2,100,000 shares of the exchange traded fund’s stock, valued at approximately $256,053,000. SPDR S&P Biotech ETF makes up approximately 2.5% of Avoro Capital Advisors LLC’s investment portfolio, making the stock its 14th biggest position. Avoro Capital Advisors LLC owned about 3.14% of SPDR S&P Biotech ETF as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Dynamic Wealth Strategies LLC boosted its stake in SPDR S&P Biotech ETF by 3.8% during the 4th quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock valued at $268,000 after purchasing an additional 80 shares in the last quarter. Capital Investment Advisory Services LLC boosted its stake in SPDR S&P Biotech ETF by 4.0% during the 4th quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock valued at $259,000 after purchasing an additional 81 shares in the last quarter. Commerce Bank boosted its stake in SPDR S&P Biotech ETF by 2.8% during the 4th quarter. Commerce Bank now owns 3,260 shares of the exchange traded fund’s stock valued at $397,000 after purchasing an additional 90 shares in the last quarter. Compass Ion Advisors LLC boosted its stake in SPDR S&P Biotech ETF by 2.6% during the 4th quarter. Compass Ion Advisors LLC now owns 3,886 shares of the exchange traded fund’s stock valued at $474,000 after purchasing an additional 97 shares in the last quarter. Finally, Moors & Cabot Inc. boosted its stake in SPDR S&P Biotech ETF by 3.8% during the 3rd quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock valued at $272,000 after purchasing an additional 100 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $135.34 on Wednesday. The stock has a fifty day moving average price of $132.91 and a two-hundred day moving average price of $127.37. The firm has a market cap of $8.63 billion, a P/E ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 1 year low of $80.90 and a 1 year high of $139.19.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.